CVI-301

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameCVI-301
Drug Alias NameThyroid hormone receptor beta agonist (CVI Pharmaceuticals)CVI-301
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionThyroid hormone receptor beta-1 agonists
TargetsThyroid hormone receptor beta
Therapy Area/IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesCVI Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesCVI Pharmaceuticals Ltd
Inactive CompaniesN/A
Active IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A